(R,R)-(-)-1,2-Diaminocyclohexane (BioDeep_00000671565)

   


代谢物信息卡片


(1R,2R)-(-)-1,2-Diaminocyclohexane

化学式: C6H14N2 (114.1157)
中文名称: (1R,2R)-(-)-1,2-环己二胺, 反式-1,2-环己二胺, (1R,2R)-(-)-1,2-二氨基环己烷
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1CCC(C(C1)N)N
InChI: InChI=1S/C6H14N2/c7-5-3-1-2-4-6(5)8/h5-6H,1-4,7-8H2/t5-,6-/m1/s1



数据库引用编号

3 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Nayan Roy, Surjatapa Nath, Pradip C Paul, T Sanjoy Singh. Fluorescence Behavior of Schiff Base-N, N'-bis(salicylidene) Trans 1, 2-Diaminocyclohexane in Proteinous and Micellar Environments. Journal of fluorescence. 2017 Nov; 27(6):2295-2311. doi: 10.1007/s10895-017-2171-6. [PMID: 28831629]
  • Benjamin W J Harper, Aviva Friedman-Ezra, Roman Sirota, Emanuele Petruzzella, Janice R Aldrich-Wright, Dan Gibson. Probing the Interactions of Cytotoxic [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)] and Its PtIV Derivatives with Human Serum. ChemMedChem. 2017 04; 12(7):510-519. doi: 10.1002/cmdc.201700092. [PMID: 28206707]
  • Mehvash Zaki, Mohd Afzal, Musheer Ahmad, Sartaj Tabassum. Synthesis and crystal structure elucidation of new copper(II)-based chemotherapeutic agent coupled with 1,2-DACH and orthovanillin: Validated by in vitro DNA/HSA binding profile and pBR322 cleavage pathway. Journal of photochemistry and photobiology. B, Biology. 2016 Aug; 161(?):318-27. doi: 10.1016/j.jphotobiol.2016.05.030. [PMID: 27289445]
  • Said S Al-Jaroudi, Muhammad Altaf, Abdulaziz A Al-Saadi, Abdel-Nasser Kawde, Saleh Altuwaijri, Saeed Ahmad, Anvarhusein A Isab. Synthesis, characterization and theoretical calculations of (1,2-diaminocyclohexane)(1,3-diaminopropane)gold(III) chloride complexes: in vitro cytotoxic evaluations against human cancer cell lines. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine. 2015 Oct; 28(5):827-44. doi: 10.1007/s10534-015-9869-1. [PMID: 26099502]
  • Hajime Ito, Hiroaki Yamaguchi, Asuka Fujikawa, Nobuaki Tanaka, Ayako Furugen, Kazuaki Miyamori, Natsuko Takahashi, Jiro Ogura, Masaki Kobayashi, Takehiro Yamada, Nariyasu Mano, Ken Iseki. A full validated hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the quantification of oxaliplatin in human plasma ultrafiltrates. Journal of pharmaceutical and biomedical analysis. 2012 Dec; 71(?):99-103. doi: 10.1016/j.jpba.2012.08.010. [PMID: 22954448]
  • Amr S Abu Lila, Noha Essam Eldin, Masako Ichihara, Tatsuhiro Ishida, Hiroshi Kiwada. Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: a possible mechanism and the potential for clinical application. International journal of pharmaceutics. 2012 Nov; 438(1-2):176-83. doi: 10.1016/j.ijpharm.2012.08.030. [PMID: 22944302]
  • Rui Wang, Xiuli Hu, Sai Wu, Haihua Xiao, Haidong Cai, Zhigang Xie, Yubin Huang, Xiabin Jing. Biological characterization of folate-decorated biodegradable polymer-platinum(II) complex micelles. Molecular pharmaceutics. 2012 Nov; 9(11):3200-8. doi: 10.1021/mp3002914. [PMID: 22954154]
  • Mei Guan, Shu-Chang Chen, Hong-Yan Ying, Lin Zhao, Xiao-Yuan Li, Jian-Feng Zhou, Ya-Juan Shao, Xian-da Yang, Yi Lin, Xiao-Hong Ning, Chun-Mei Bai. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases. Chinese medical journal. 2012 Oct; 125(20):3640-5. doi: NULL. [PMID: 23075717]
  • Murat Zor, Ibrahim Yildirim, Seref Basal, Halil Yaman, Mustafa Ozturk, Cem Hasan Irkilata, Serdar Goktas, Murat Dayanc. Intralymphatic delivery of platinum-based chemotherapeutics is possible: an experimental study. Journal of cancer research and clinical oncology. 2012 Oct; 138(10):1679-82. doi: 10.1007/s00432-012-1245-8. [PMID: 22638885]
  • Shereen Mowaka, Matthias Ziehe, Dalia Mohamed, Ulrike Hochkirch, Jürgen Thomale, Michael W Linscheid. Structures of oxaliplatin-oligonucleotide adducts from DNA. Journal of mass spectrometry : JMS. 2012 Oct; 47(10):1282-93. doi: 10.1002/jms.3080. [PMID: 23019159]
  • Paolo B Abada, Christopher A Larson, Gerald Manorek, Preston Adams, Stephen B Howell. Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A. Molecular pharmacology. 2012 Sep; 82(3):510-20. doi: 10.1124/mol.112.079822. [PMID: 22710939]
  • Jung Soo Lee, Yoon Tae Kim, Eun Kyoung Jeon, Hye Sung Won, Young-Seok Cho, Yoon Ho Ko. Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats. BMC complementary and alternative medicine. 2012 Aug; 12(?):124. doi: 10.1186/1472-6882-12-124. [PMID: 22894541]
  • Melanie Orgel, Marius Horger, Ralph Kurth, Lothar Kanz, Karl Jaschonek, Frank Mayer, Hans-Georg Kopp. [Severe hemorrhage in a patient with metastatic colorectal cancer - case 8/2012]. Deutsche medizinische Wochenschrift (1946). 2012 Aug; 137(34-35):1705. doi: 10.1055/s-0032-1305227. [PMID: 22893052]
  • Yong Zhang, Xiao-wen Sun, Jian-hua Xu, Hai Lu, Zhong-ze Fan, Jue Sun, Xiao-xiao Zhang. [Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells]. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine. 2012 Aug; 10(8):901-10. doi: 10.3736/jcim20120811. [PMID: 22883407]
  • Laurie Menger, Erika Vacchelli, Sandy Adjemian, Isabelle Martins, Yuting Ma, Shensi Shen, Takahiro Yamazaki, Abdul Qader Sukkurwala, Mickaël Michaud, Grégoire Mignot, Frederic Schlemmer, Eric Sulpice, Clara Locher, Xavier Gidrol, François Ghiringhelli, Nazanine Modjtahedi, Lorenzo Galluzzi, Fabrice André, Laurence Zitvogel, Oliver Kepp, Guido Kroemer. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Science translational medicine. 2012 Jul; 4(143):143ra99. doi: 10.1126/scitranslmed.3003807. [PMID: 22814852]
  • Ayumu Hosokawa, Kohei Ogawa, Takayuki Ando, Nobuhiro Suzuki, Akira Ueda, Shinya Kajiura, Yuka Kobayashi, Yuji Tsukioka, Naoki Horikawa, Kazuhisa Yabushita, Junya Fukuoka, Toshiro Sugiyama. Preventive effect of traditional Japanese medicine on neurotoxicity of FOLFOX for metastatic colorectal cancer: a multicenter retrospective study. Anticancer research. 2012 Jul; 32(7):2545-50. doi: ". [PMID: 22753712]
  • Mohamad Farid, Balram Chowbay, Xiangai Chen, Sze Huey Tan, Saminathan Ramasamy, Wen Hsin Koo, Han Chong Toh, Su Pin Choo, Simon Yew Kuang Ong. Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer. Cancer chemotherapy and pharmacology. 2012 Jul; 70(1):141-50. doi: 10.1007/s00280-012-1895-x. [PMID: 22648745]
  • Paul J Hesketh, Oliver Wright, Gerardo Rosati, Mark Russo, Jeremey Levin, Stephen Lane, Vladimir Moiseyenko, Pierre Dube, Mikhail Kopp, Anatoly Makhson. Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2012 Jul; 20(7):1471-8. doi: 10.1007/s00520-011-1235-4. [PMID: 21822913]
  • Yoichi Toyama, Takuro Ushigome, Kazuhiro Watanabe, Hiroaki Kitamura, Shinji Onda, Ryota Saito, Seiya Yoshida, Hidejiro Kawahara, Satoru Yanagisawa, Katsuhiko Yanaga. Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report. World journal of surgical oncology. 2012 Jun; 10(?):129. doi: 10.1186/1477-7819-10-129. [PMID: 22747970]
  • Miroslav Huličiak, Jan Vacek, Marek Sebela, Eva Orolinová, Joanna Znaleziona, Marika Havlíková, Martin Kubala. Covalent binding of cisplatin impairs the function of Na(+)/K(+)-ATPase by binding to its cytoplasmic part. Biochemical pharmacology. 2012 Jun; 83(11):1507-13. doi: 10.1016/j.bcp.2012.02.015. [PMID: 22394404]
  • Kazumi Tanaka, Keitaro Hirai, Hiroomi Ogawa, Hiroyuki Toya, Osamu Totsuka, Daisuke Yoshinari, Yutaka Sunose, Izumi Takeyoshi. [A case of advanced colon cancer with peritoneal dissemination effectively treated with modified FOLFOX6 chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy. 2012 Jun; 39(6):993-5. doi: NULL. [PMID: 22705700]
  • Twisha Chakravarty, Christopher H Crane, Jaffer A Ajani, Paul F Mansfield, Tina M Briere, A Sam Beddar, Henry Mok, Valerie K Reed, Sunil Krishnan, Marc E Delclos, Prajnan Das. Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma. International journal of radiation oncology, biology, physics. 2012 Jun; 83(2):581-6. doi: 10.1016/j.ijrobp.2011.07.035. [PMID: 22137021]
  • Sara Zalba, Iñigo Navarro, Iñaki F Trocóniz, Conchita Tros de Ilarduya, María J Garrido. Application of different methods to formulate PEG-liposomes of oxaliplatin: evaluation in vitro and in vivo. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2012 Jun; 81(2):273-80. doi: 10.1016/j.ejpb.2012.02.007. [PMID: 22369879]
  • Yan Zhang, Jia Yuan, Hong Yan Zhang, Dilixia Simayi, Pin Dong Li, Ying Hong Wang, Feng Li, Wen Jie Zhang. Natural resistance to apoptosis correlates with resistance to chemotherapy in colorectal cancer cells. Clinical and experimental medicine. 2012 Jun; 12(2):97-103. doi: 10.1007/s10238-011-0146-5. [PMID: 21688119]
  • Giacomo Allegrini, Teresa Di Desidero, Maria Teresa Barletta, Anna Fioravanti, Paola Orlandi, Bastianina Canu, Silvio Chericoni, Fotios Loupakis, Antonello Di Paolo, Gianluca Masi, Andrea Fontana, Sara Lucchesi, Giada Arrighi, Mario Giusiani, Andrea Ciarlo, Giovanni Brandi, Romano Danesi, Robert S Kerbel, Alfredo Falcone, Guido Bocci. Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers. Angiogenesis. 2012 Jun; 15(2):275-86. doi: 10.1007/s10456-012-9260-6. [PMID: 22382585]
  • Isao Ito, Yasuhiko Ito, Masashi Mizuno, Yasuhiro Suzuki, Kaoru Yasuda, Takenori Ozaki, Tomoki Kosugi, Yoshinari Yasuda, Waichi Sato, Naotake Tsuboi, Shoichi Maruyama, Enyu Imai, Seiichi Matsuo. A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin. Clinical and experimental nephrology. 2012 Jun; 16(3):490-4. doi: 10.1007/s10157-012-0620-8. [PMID: 22450906]
  • Yvonne Wettergren, Göran Carlsson, Elisabeth Odin, Bengt Gustavsson. Pretherapeutic uracil and dihydrouracil levels of colorectal cancer patients are associated with sex and toxic side effects during adjuvant 5-fluorouracil-based chemotherapy. Cancer. 2012 Jun; 118(11):2935-43. doi: 10.1002/cncr.26595. [PMID: 22020693]
  • Marisa Mariani, Gian Franco Zannoni, Stefano Sioletic, Steven Sieber, Candice Martino, Enrica Martinelli, Claudio Coco, Giovanni Scambia, Shohreh Shahabi, Cristiano Ferlini. Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 May; 18(10):2964-75. doi: 10.1158/1078-0432.ccr-11-2318. [PMID: 22438565]
  • Haihua Xiao, Dongfang Zhou, Shi Liu, Yonghui Zheng, Yubin Huang, Xiabin Jing. A complex of cyclohexane-1,2-diaminoplatinum with an amphiphilic biodegradable polymer with pendant carboxyl groups. Acta biomaterialia. 2012 May; 8(5):1859-68. doi: 10.1016/j.actbio.2012.01.007. [PMID: 22281944]
  • Mao-rong Wang, Xin Zhang, Yan-qing Liu. [Acetoacetate extract from Celastrus orbiculatus Thunb inhibits growth of RFP-xenografted human liver carcinoma]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 2012 May; 20(5):377-80. doi: 10.3760/cma.j.issn.1007-3418.2012.05.015. [PMID: 22971285]
  • Yuji Wang, Guifeng Kang, Jiawang Liu, Ming Zhao, Jianhui Wu, Xiaoyi Zhang, Ye Li, Xiaobo Zhong, Yifan Yang, Shiqi Peng. Novel potassium N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxylhex-1-yl]-L-amino acid dichloroplatinates(II) with high anti-tumor activity and low side reaction. Metallomics : integrated biometal science. 2012 May; 4(5):441-7. doi: 10.1039/c2mt00005a. [PMID: 22488043]
  • Teijiro Hirashita, Yukio Iwashita, Masayuki Ohta, Yoko Komori, Hidetoshi Eguchi, Kazuhiro Yada, Seigo Kitano. Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2012 Apr; 16(4):842-8. doi: 10.1007/s11605-011-1813-2. [PMID: 22246855]
  • Samudi Chandramathi, Kumar Suresh, Zarina Bustam Anita, Umah Rani Kuppusamy. Infections of Blastocystis hominis and microsporidia in cancer patients: are they opportunistic?. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2012 Apr; 106(4):267-9. doi: 10.1016/j.trstmh.2011.12.008. [PMID: 22340948]
  • Maorong Wang, Xin Zhang, Xi Xiong, Zhiguo Yang, Yu Sun, Zhijian Yang, Robert M Hoffman, Yanqing Liu. Efficacy of the Chinese traditional medicinal herb Celastrus orbiculatus Thunb on human hepatocellular carcinoma in an orthothopic fluorescent nude mouse model. Anticancer research. 2012 Apr; 32(4):1213-20. doi: ". [PMID: 22493351]
  • C L King, S Ramachandran, S G Chaney, L Collins, J A Swenberg, K E DeKrafft, W Lin, L Cicurel, M Barbier. Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells. Cancer chemotherapy and pharmacology. 2012 Mar; 69(3):665-77. doi: 10.1007/s00280-011-1744-3. [PMID: 21968950]
  • Lorenzo Di Cesare Mannelli, Matteo Zanardelli, Paola Failli, Carla Ghelardini. Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. The journal of pain. 2012 Mar; 13(3):276-84. doi: 10.1016/j.jpain.2011.11.009. [PMID: 22325298]
  • H Bleiberg, A Vandebroek, I Deleu, P Vergauwe, H Rezaei Kalantari, G D'Haens, M Paesmans, M Peeters, A Efira, Y Humblet. A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer. Acta gastro-enterologica Belgica. 2012 Mar; 75(1):14-21. doi: NULL. [PMID: 22567742]
  • Abhimanyu Paraskar, Shivani Soni, Bhaskar Roy, Anne-Laure Papa, Shiladitya Sengupta. Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy. Nanotechnology. 2012 Feb; 23(7):075103. doi: 10.1088/0957-4484/23/7/075103. [PMID: 22275055]
  • Rubul Mout, Zhi-Dong Xu, Angela K H Wolf, Vincent Jo Davisson, Gotam K Jarori. Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii. Malaria journal. 2012 Feb; 11(?):54. doi: 10.1186/1475-2875-11-54. [PMID: 22361388]
  • Kohji Takara, Megumi Fujita, Tetsuya Minegaki, Kazuhiro Yamamoto, Minoru Takahashi, Teruyoshi Yokoyama, Katsuhiko Okumura. Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2012 Feb; 45(3):272-81. doi: 10.1016/j.ejps.2011.11.023. [PMID: 22155546]
  • Deepti Gholap, Johanna Verhulst, Wim Ceelen, Frank Vanhaecke. Use of pneumatic nebulization and laser ablation-inductively coupled plasma-mass spectrometry to study the distribution and bioavailability of an intraperitoneally administered Pt-containing chemotherapeutic drug. Analytical and bioanalytical chemistry. 2012 Feb; 402(6):2121-9. doi: 10.1007/s00216-011-5654-3. [PMID: 22252654]
  • Shoaib Afzal, Søren Astrup Jensen, Jens Benn Sørensen, Trine Henriksen, Allan Weimann, Henrik Enghusen Poulsen. Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin. Cancer chemotherapy and pharmacology. 2012 Feb; 69(2):301-7. doi: 10.1007/s00280-011-1700-2. [PMID: 21710244]
  • Tam T T N Nguyen, Jesper Østergaard, Stefan Stürup, Bente Gammelgaard. Investigation of a liposomal oxaliplatin drug formulation by capillary electrophoresis hyphenated to inductively coupled plasma mass spectrometry (CE-ICP-MS). Analytical and bioanalytical chemistry. 2012 Feb; 402(6):2131-9. doi: 10.1007/s00216-011-5651-6. [PMID: 22245979]
  • Amteshwar Singh Jaggi, Nirmal Singh. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology. 2012 Jan; 291(1-3):1-9. doi: 10.1016/j.tox.2011.10.019. [PMID: 22079234]
  • Mohammad Rezaee, Elahe Alizadeh, Darel Hunting, Léon Sanche. DNA-Platinum Thin Films for Use in Chemoradiation Therapy Studies. Bioinorganic chemistry and applications. 2012; 2012(?):923914. doi: 10.1155/2012/923914. [PMID: 21977010]
  • Rajesh R Kaldate, Abebe Haregewoin, Charles E Grier, Stephanie A Hamilton, Howard L McLeod. Modeling the 5-fluorouracil area under the curve versus dose relationship to develop a pharmacokinetic dosing algorithm for colorectal cancer patients receiving FOLFOX6. The oncologist. 2012; 17(3):296-302. doi: 10.1634/theoncologist.2011-0357. [PMID: 22382460]
  • Jeffrey A Meyerhardt, Marek Ancukiewicz, Thomas A Abrams, Deborah Schrag, Peter C Enzinger, Jennifer A Chan, Matthew H Kulke, Brian M Wolpin, Michael Goldstein, Lawrence Blaszkowsky, Andrew X Zhu, Meaghan Elliott, Eileen Regan, Rakesh K Jain, Dan G Duda. Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer. PloS one. 2012; 7(6):e38231. doi: 10.1371/journal.pone.0038231. [PMID: 22701615]
  • Atsushi Yonezawa. [Platinum agent-induced nephrotoxicity via organic cation transport system]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2012; 132(11):1281-5. doi: 10.1248/yakushi.12-00211. [PMID: 23123720]
  • Wei Wang, Fang Zhou, Linfu Ge, Ximin Liu, Fansheng Kong. Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. International journal of nanomedicine. 2012; 7(?):2513-22. doi: 10.2147/ijn.s31915. [PMID: 22679364]
  • Lauren E Seber, Brian W Barnett, Elizabeth J McConnell, Steven D Hume, Jian Cai, Kati Boles, Keith R Davis. Scalable purification and characterization of the anticancer lunasin peptide from soybean. PloS one. 2012; 7(4):e35409. doi: 10.1371/journal.pone.0035409. [PMID: 22514740]
  • Mario Scartozzi, Luca Faloppi, Maristella Bianconi, Riccardo Giampieri, Elena Maccaroni, Alessandro Bittoni, Michela Del Prete, Cristian Loretelli, Laura Belvederesi, Gianluca Svegliati Baroni, Stefano Cascinu. The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. PloS one. 2012; 7(3):e32653. doi: 10.1371/journal.pone.0032653. [PMID: 22461886]
  • Søren Astrup Jensen, Jens Benn Sørensen. 5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity. Cancer chemotherapy and pharmacology. 2012 Jan; 69(1):57-64. doi: 10.1007/s00280-011-1669-x. [PMID: 21603868]
  • Paul H Sugarbaker, David Chang, O Anthony Stuart. Hyperthermic intraoperative thoracoabdominal chemotherapy. Gastroenterology research and practice. 2012; 2012(?):623417. doi: 10.1155/2012/623417. [PMID: 22654899]
  • Peyman Kabolizadeh, Brigitte J Engelmann, Nicholas Pullen, Jennifer K Stewart, John J Ryan, Nicholas P Farrell. Platinum anticancer agents and antidepressants: desipramine enhances platinum-based cytotoxicity in human colon cancer cells. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry. 2012 Jan; 17(1):123-32. doi: 10.1007/s00775-011-0836-1. [PMID: 21918844]
  • Heidrun Weidemann. 'The Lower Threshold' phenomenon in tumor cells toward endogenous digitalis-like compounds: Responsible for tumorigenesis?. Journal of carcinogenesis. 2012; 11(?):2. doi: 10.4103/1477-3163.92999. [PMID: 22438768]
  • Chandrajit P Raut, Yves Boucher, Dan G Duda, Jeffrey A Morgan, Richard Quek, Marek Ancukiewicz, Johanna Lahdenranta, J Paul Eder, George D Demetri, Rakesh K Jain. Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948). PloS one. 2012; 7(2):e26331. doi: 10.1371/journal.pone.0026331. [PMID: 22347360]
  • Kenji Hashimoto, Yuko Sasajima, Masashi Ando, Kan Yonemori, Akihiro Hirakawa, Koh Furuta, Hitoshi Tsuda, Yasuhiro Fujiwara. Immunohistochemical profile for unknown primary adenocarcinoma. PloS one. 2012; 7(1):e31181. doi: 10.1371/journal.pone.0031181. [PMID: 22299055]
  • Roberto Petrioli, Antonella Licchetta, Giandomenico Roviello, Alessandra Pascucci, Edoardo Francini, Gianluca Bargagli, Raffaele Conca, Salvatora Tindara Miano, Giuseppe Marzocca, Guido Francini. CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab. Cancer investigation. 2012 Jan; 30(1):65-71. doi: 10.3109/07357907.2011.629380. [PMID: 22236191]
  • Yi Chen, Xiaolin Wang, Zhiping Yan, Jianhua Wang, Jianjun Luo, Qingxin Liu. Hepatic arterial infusion with irinotecan, oxaliplatin, and floxuridine plus systemic chemotherapy as first-line treatment of unresectable liver metastases from colorectal cancer. Onkologie. 2012; 35(9):480-4. doi: 10.1159/000341825. [PMID: 23007144]
  • S Jennane, K Doghmi, E M Mahtat, N Messaoudi, B Varet, M Mikdame. Bing and neel syndrome. Case reports in hematology. 2012; 2012(?):845091. doi: 10.1155/2012/845091. [PMID: 22988532]
  • Motoko Kanzaki, Jun Wada, Atsuko Nakatsuka, Sanae Teshigawara, Kazutoshi Murakami, Kentaro Inoue, Takahiro Terami, Akihiro Katayama, Junichiro Nasu, Kazuhide Yamamoto, Hirofumi Makino. A case of type 2 diabetes and metastatic liver cancer exhibiting hypercholesterolemia with abnormal lipoproteins. Internal medicine (Tokyo, Japan). 2012; 51(6):619-23. doi: 10.2169/internalmedicine.51.6486. [PMID: 22449671]
  • Ayako Mizota, Kohei Shitara, Chihiro Kondo, Motoo Nomura, Tomoya Yokota, Daisuke Takahari, Takashi Ura, Kei Muro. A case of heavily pretreated rectal cancer with disseminated intravascular coagulation that improved following reintroduction of FOLFOX plus bevacizumab. International journal of clinical oncology. 2011 Dec; 16(6):766-9. doi: 10.1007/s10147-011-0242-2. [PMID: 21560034]
  • Thititip Tippayamontri, Rami Kotb, Benoit Paquette, Léon Sanche. Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116. Investigational new drugs. 2011 Dec; 29(6):1321-7. doi: 10.1007/s10637-010-9494-3. [PMID: 20658169]
  • Yuji Wang, Guifeng Kang, Ming Zhao, Jianhui Wu, Xiaoyi Zhang, Yifan Yang, Jiawang Liu, Shiqi Peng. A new platinum-complex showing easy preparation, promising anti-tumor activity, and better efficacy and distribution properties than oxaliplatin. Molecular bioSystems. 2011 Dec; 7(12):3245-52. doi: 10.1039/c1mb05266g. [PMID: 22008999]
  • Maurice C van Staveren, Barbara Theeuwes-Oonk, Henk Jan Guchelaar, André B P van Kuilenburg, Jan Gerard Maring. Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency. Cancer chemotherapy and pharmacology. 2011 Dec; 68(6):1611-7. doi: 10.1007/s00280-011-1661-5. [PMID: 21590448]
  • Dohan Weeraratne, Alin Chen, Jason J Pennucci, Chi-Yuan Wu, Kathy Zhang, Jacqueline Wright, Juan José Pérez-Ruixo, Bing-Bing Yang, Arunan Kaliyaperumal, Shalini Gupta, Steven J Swanson, Narendra Chirmule, Marta Starcevic. Immunogenicity of panitumumab in combination chemotherapy clinical trials. BMC clinical pharmacology. 2011 Nov; 11(?):17. doi: 10.1186/1472-6904-11-17. [PMID: 22070868]
  • Brad T Benedetti, Susana Quintal, Nicholas P Farrell. Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds. Dalton transactions (Cambridge, England : 2003). 2011 Nov; 40(41):10983-8. doi: 10.1039/c1dt10964b. [PMID: 21918760]
  • Hiroshi Kuwabara, Hironobu Baba, Mai Wakabayashi, Hiroshi Nakamura, Takahiro Sanada, Hiroyuki Baba, Kazumi Nakajima, Narihide Goseki. [mFOLFOX6 and FOLFIRI/bevacizumab treatment in a patient on hemodialysis with metastatic colon cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 2011 Nov; 38(12):2250-2. doi: NULL. [PMID: 22202345]
  • E Hinchliffe, R L Allcock, W Mansoor, M A Myers. A patient with a metastatic gastroenteropancreatic endocrine carcinoma causing hyperinsulinaemic hypoglycaemia and the carcinoid syndrome. Annals of clinical biochemistry. 2011 Nov; 48(Pt 6):579-83. doi: 10.1258/acb.2011.011068. [PMID: 21948491]
  • Hong Jae Chon, Sun Young Rha, Hyung Soon Park, Sang Joon Shin, Hyo Song Kim, Jae Kyung Roh, Sung Hoon Noh, Hyun Cheol Chung, Hei-Cheul Jeung. Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer. Cancer chemotherapy and pharmacology. 2011 Oct; 68(4):991-9. doi: 10.1007/s00280-011-1560-9. [PMID: 21327684]
  • Aref Zayed, George D D Jones, Helen J Reid, Tamer Shoeib, Sarah E Taylor, Anne L Thomas, Joanna P Wood, Barry L Sharp. Speciation of oxaliplatin adducts with DNA nucleotides. Metallomics : integrated biometal science. 2011 Oct; 3(10):991-1000. doi: 10.1039/c1mt00041a. [PMID: 21858382]
  • T Kampfenkel, I Tischoff, H Bonhag, M Eckardt, W Schmiegel, A Tannapfel, A Reinacher-Schick, R Viebahn. [Chemotherapy-associated steatohepatitis in patients with colorectal cancer and surgery on hepatic metastasis: clinical validation of a histopathological scoring system and preoperative risk assessment]. Zeitschrift fur Gastroenterologie. 2011 Oct; 49(10):1407-11. doi: 10.1055/s-0031-1281749. [PMID: 21964894]
  • Thomas Mueller, Wieland Voigt. Fermented wheat germ extract--nutritional supplement or anticancer drug?. Nutrition journal. 2011 Sep; 10(?):89. doi: 10.1186/1475-2891-10-89. [PMID: 21892933]
  • Annabelle Ballesta, Sandrine Dulong, Chadi Abbara, Boris Cohen, Alper Okyar, Jean Clairambault, Francis Levi. A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery. PLoS computational biology. 2011 Sep; 7(9):e1002143. doi: 10.1371/journal.pcbi.1002143. [PMID: 21931543]
  • Marco Agostini, Salvatore Pucciarelli, Maria Vittoria Enzo, Paola Del Bianco, Marta Briarava, Chiara Bedin, Isacco Maretto, Maria Luisa Friso, Sara Lonardi, Claudia Mescoli, Paola Toppan, Emanuele Urso, Donato Nitti. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy. Annals of surgical oncology. 2011 Sep; 18(9):2461-8. doi: 10.1245/s10434-011-1638-y. [PMID: 21416156]
  • Rosalinda Guerrero, Ashish Bhargava, Zeina Nahleh. Rhodococcus equi venous catheter infection: a case report and review of the literature. Journal of medical case reports. 2011 Aug; 5(?):358. doi: 10.1186/1752-1947-5-358. [PMID: 21827681]
  • Jürgen Eckes, Oliver Schmah, Jan W Siebers, Ursula Groh, Stefan Zschiedrich, Beate Rautenberg, Annette Hasenburg, Martin Jansen, Martin J Hug, Karl Winkler, Gerhard Pütz. Kinetic targeting of pegylated liposomal doxorubicin: a new approach to reduce toxicity during chemotherapy (CARL-trial). BMC cancer. 2011 Aug; 11(?):337. doi: 10.1186/1471-2407-11-337. [PMID: 21816044]
  • Regina M Leger, George Garratty. Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors. Transfusion. 2011 Aug; 51(8):1740-4. doi: 10.1111/j.1537-2995.2010.03040.x. [PMID: 21303372]
  • Nancy N Jong, Takeo Nakanishi, Johnson J Liu, Ikumi Tamai, Mark J McKeage. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons. The Journal of pharmacology and experimental therapeutics. 2011 Aug; 338(2):537-47. doi: 10.1124/jpet.111.181297. [PMID: 21606177]
  • Bo Cao, Shao-tang Li, Zhi Li, Wen-ling Deng. Yiqi zhuyu decoction combined with FOLFOX-4 as first-line therapy in metastatic colorectal cancer. Chinese journal of integrative medicine. 2011 Aug; 17(8):593-9. doi: 10.1007/s11655-011-0822-z. [PMID: 21826593]
  • Klaus Mross, Annette Frost, Max E Scheulen, Jürgen Krauss, Dirk Strumberg, Beate Schultheiss, Ulrike Fasol, Martin Büchert, Jörn Krätzschmer, Heinz Delesen, Prabhu Rajagopalan, Olaf Christensen. Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer. Vascular cell. 2011 Jul; 3(?):16. doi: 10.1186/2045-824x-3-16. [PMID: 21801343]
  • Wen Tan, Jinjian Lu, Mingqing Huang, Yingbo Li, Meiwan Chen, Guosheng Wu, Jian Gong, Zhangfeng Zhong, Zengtao Xu, Yuanye Dang, Jiajie Guo, Xiuping Chen, Yitao Wang. Anti-cancer natural products isolated from chinese medicinal herbs. Chinese medicine. 2011 Jul; 6(1):27. doi: 10.1186/1749-8546-6-27. [PMID: 21777476]
  • Piroska Virag, Ioana Brie, Eva Fischer-Fodor, Maria Perde-Schrepler, Corina Tatomir, Ovidiu Balacescu, Alexandru Irimie, Ion Dan Postescu. Assessment of cytotoxicity, apoptosis and DNA damages in Colo320 colorectal cancer cells selected for oxaliplatin resistance. Cell biochemistry and function. 2011 Jul; 29(5):351-5. doi: 10.1002/cbf.1754. [PMID: 21491469]
  • Takahiro Horimatsu, Shin'ichi Miyamoto, Shuko Morita, Yoko Mashimo, Yasumasa Ezoe, Manabu Muto, Tsutomu Chiba. Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy. Cancer chemotherapy and pharmacology. 2011 Jul; 68(1):263-6. doi: 10.1007/s00280-011-1633-9. [PMID: 21499694]
  • Ken Houben, Ruben P Jolie, Ilse Fraeye, Ann M Van Loey, Marc E Hendrickx. Comparative study of the cell wall composition of broccoli, carrot, and tomato: structural characterization of the extractable pectins and hemicelluloses. Carbohydrate research. 2011 Jul; 346(9):1105-11. doi: 10.1016/j.carres.2011.04.014. [PMID: 21536260]
  • Ayako Mizota, Kohei Shitara, Chihiro Kondo, Motoo Nomura, Tomoya Yokota, Daisuke Takahari, Takashi Ura, Kei Muro. FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastases. Gan to kagaku ryoho. Cancer & chemotherapy. 2011 Jul; 38(7):1205-8. doi: NULL. [PMID: 21772113]
  • Clarisse S Muenyi, Vanessa A States, Joshua H Masters, Teresa W Fan, C William Helm, J Christopher States. Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC). Journal of ovarian research. 2011 Jun; 4(?):9. doi: 10.1186/1757-2215-4-9. [PMID: 21696631]
  • Takuya Osada, Minyong Chen, Xiao Yi Yang, Ivan Spasojevic, Jeffrey B Vandeusen, David Hsu, Bryan M Clary, Timothy M Clay, Wei Chen, Michael A Morse, H Kim Lyerly. Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. Cancer research. 2011 Jun; 71(12):4172-82. doi: 10.1158/0008-5472.can-10-3978. [PMID: 21531761]
  • Hironori Fujii, Hirotoshi Iihara, Koji Yasuda, Katsuhiko Matsuura, Takao Takahashi, Kazuhiro Yoshida, Yoshinori Itoh. Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy. Medical oncology (Northwood, London, England). 2011 Jun; 28(2):488-93. doi: 10.1007/s12032-010-9487-2. [PMID: 20354823]
  • Chi-Hui Tang, Christi Parham, Ellyn Shocron, Gerald McMahon, Neela Patel. Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin. Cancer chemotherapy and pharmacology. 2011 Jun; 67(6):1389-400. doi: 10.1007/s00280-010-1435-5. [PMID: 20809122]
  • Peter-Michael Krieger, Dietmar Tamandl, Beata Herberger, Peter Faybik, Edith Fleischmann, Judith Maresch, Thomas Gruenberger. Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing. Annals of surgical oncology. 2011 Jun; 18(6):1644-50. doi: 10.1245/s10434-010-1494-1. [PMID: 21207168]
  • J Randolph Hecht, Tanja Trarbach, John D Hainsworth, Pierre Major, Elke Jäger, Robert A Wolff, Katherine Lloyd-Salvant, György Bodoky, Kelly Pendergrass, William Berg, Bee-Lian Chen, Tarja Jalava, Gerold Meinhardt, Dirk Laurent, David Lebwohl, David Kerr. Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 May; 29(15):1997-2003. doi: 10.1200/jco.2010.29.4496. [PMID: 21464406]
  • U Wallin, B Glimelius, K Jirström, S Darmanis, R Y Nong, F Pontén, C Johansson, L Påhlman, H Birgisson. Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer. British journal of cancer. 2011 May; 104(10):1619-27. doi: 10.1038/bjc.2011.112. [PMID: 21468045]
  • Li Tang, Lie-Jun Mei, Xiao-Jun Yang, Chao-Qun Huang, Yun-Feng Zhou, Yutaka Yonemura, Yan Li. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study. Journal of translational medicine. 2011 May; 9(?):53. doi: 10.1186/1479-5876-9-53. [PMID: 21548973]
  • Keiichiro Hiramoto, Michio Kuroki, Eriko Nakano, Nana Kanno, Yoshifumi Matsumura, Atsushi Miura, Yoshifumi Kikuchi, Hidetoshi Hirakawa. [Successful management with partial splenic embolization (PSE) of splenomegaly and thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 2011 May; 38(5):835-9. doi: NULL. [PMID: 21566449]
  • Qing-chao Zhu, Zhi-ming Jin. [Efficacy and side effects of combination therapy of oxaliplatin and S-1 for colorectal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology]. 2011 May; 33(5):388-90. doi: NULL. [PMID: 21875473]
  • B Vincenzi, S Galluzzo, D Santini, L Rocci, F Loupakis, P Correale, R Addeo, A Zoccoli, A Napolitano, F Graziano, A Ruzzo, A Falcone, G Francini, G Dicuonzo, G Tonini. Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology. 2011 May; 22(5):1141-1146. doi: 10.1093/annonc/mdq550. [PMID: 21115601]
  • Bettina M Kaminski, Andreas Weigert, Bernhard Brüne, Marco Schumacher, Uwe Wenzel, Dieter Steinhilber, Jürgen Stein, Sandra Ulrich. Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death. Cancer chemotherapy and pharmacology. 2011 May; 67(5):1167-78. doi: 10.1007/s00280-010-1413-y. [PMID: 20689952]
  • Ulrik Franzen, Tam T T N Nguyen, Charlotte Vermehren, Bente Gammelgaard, Jesper Ostergaard. Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage. Journal of pharmaceutical and biomedical analysis. 2011 Apr; 55(1):16-22. doi: 10.1016/j.jpba.2010.12.037. [PMID: 21282028]